A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81

Abstract

Hepatitis C virus (HCV) is a species-specific pathogenic virus that infects only humans and chimpanzees. Previous studies have indicated that interactions between the HCV E2 protein and CD81 on host cells are required for HCV infection. To determine the crucial factors for species-specific interactions at the molecular level, this study employed in silico molecular docking involving molecular dynamic simulations of the binding of HCV E2 onto human and rat CD81s. In vitro experiments including surface plasmon resonance measurements and cellular binding assays were applied for simple validations of the in silico results. The in silico studies identified two binding regions on the HCV E2 loop domain, namely E2-site1 and E2-site2, as being crucial for the interactions with CD81s, with the E2-site2 as the determinant factor for human-specific binding. Free energy calculations indicated that the E2/CD81 binding process might follow a two-step model involving (i) the electrostatic interaction-driven initial binding of human-specific E2-site2, followed by (ii) changes in the E2 orientation to facilitate the hydrophobic and van der Waals interaction-driven binding of E2-site1. The sequence of the human-specific, stronger-binding E2-site2 could serve as a candidate template for the future development of HCV-inhibiting peptide drugs.

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

“…The binding regions of the E1 glycoprotein-IONPs complex Figure 4 and 5 are surrounded by amino acid residues Val75, Gly76, Ser77, Ala78 and Gly97 as reported previously Chang et al, 2017. This differed from the binding region for E2 glycoprotein-IONPs complex (Figs.…”

Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics

“…The HCV envelope glycoprotein E2 also colocalizes with CD81 and cells that internalize EVs containing this complex are more susceptible to HCV infection 49 , 52 . Interaction with this complex may also promote HCV uptake by EVs 53 , 54 . Studies suggest that EV proteins may facilitate viral-receptor-independent transmission of HCV and HAV, and presumably other EV-enveloped viruses, to uninfected cells 43 , 49 .…”

COMT-Catalyzed Palmitic Acid Methyl Ester Biosynthesis in Perivascular Adipose Tissue and its Potential Role Against Hypertension

“…We assumed that the receptor and ligand behaved similarly during binding, which was reasonable and adoptable for our simulations. The free energy calculations have been explained in detail previously (Jiang et al, 2015;Chang et al, 2017). To calculate all energy terms, extracted 300 snapshots from 30 (170-200)-ns molecular docking trajectories per system.…”